Co-Authors
This is a "connection" page, showing publications co-authored by Graham Cooke and Deborah Ashby.
Connection Strength
0.574
-
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax. 2020 12; 75(12):1082-1088.
Score: 0.224
-
Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance. Clin Infect Dis. 2021 05 04; 72(9):e384-e393.
Score: 0.059
-
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults. Lancet Reg Health Eur. 2021 May; 4:100098.
Score: 0.059
-
Resurgence of SARS-CoV-2: Detection by community viral surveillance. Science. 2021 05 28; 372(6545):990-995.
Score: 0.059
-
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study. BMJ. 2021 03 02; 372:n423.
Score: 0.058
-
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021 02 10; 12(1):905.
Score: 0.058
-
REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol. Wellcome Open Res. 2020; 5:200.
Score: 0.056